Ravn K, Wibrand F, Hansen F J, Horn N, Rosenberg T, Schwartz M
Department of Clinical Genetics, University Hospital, Rigshospitalet, Copenhagen, Denmark.
Eur J Hum Genet. 2001 Oct;9(10):805-9. doi: 10.1038/sj.ejhg.5200712.
We report a novel point mutation in the gene for the mitochondrially encoded ND6 subunit of the NADH:ubiquinone oxidoreductase (complex I of the respiratory chain) in a patient with MELAS syndrome. The mutation causes a change from alanine to valine in the most conserved region of the ND6 subunit. The patient was heteroplasmic for the mutation in both muscle and blood, but the mutation was not detected in the patient's mother. A marked reduction of complex I activity was found in the patient's muscular tissue. This is the first report of a mutation in the ND6 subunit causing MELAS. Our data confirm the genetic heterogeneity in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome, and confirms that MELAS can be caused by mutation in polypeptide-coding mtDNA genes.
我们报告了1例患有线粒体脑肌病伴乳酸血症和卒中样发作(MELAS)综合征患者,其线粒体编码的烟酰胺腺嘌呤二核苷酸(NADH):泛醌氧化还原酶(呼吸链复合体I)ND6亚基基因存在一种新的点突变。该突变导致ND6亚基最保守区域的丙氨酸变为缬氨酸。患者肌肉和血液中的该突变均为异质性,但在患者母亲中未检测到该突变。在患者的肌肉组织中发现复合体I活性显著降低。这是首次报道ND6亚基突变导致MELAS。我们的数据证实了线粒体脑肌病、乳酸酸中毒和卒中样发作综合征中的遗传异质性,并证实MELAS可由多肽编码的线粒体DNA(mtDNA)基因突变引起。